Hamburg Hall Controversy session

Micrometastatic node positive disease should be considered as node-negative for systemic treatment decisions (ID 23)

Date
Fri, 12.05.2023
Time
09:00 - 10:00
Room
Hamburg Hall
Chairs
  • Peter Dubsky (Luzern, Switzerland)
Micrometastatic node positive disease should be considered as node-negative for systemic treatment decisions

Introduction and first vote (ID 71)

Lecture Time
09:00 - 09:10
Session Name
Micrometastatic node positive disease should be considered as node-negative for systemic treatment decisions
Room
Hamburg Hall
Date
Fri, 12.05.2023
Time
09:00 - 10:00
Speakers
  • Peter Dubsky (Luzern, Switzerland)
Authors
  • Peter Dubsky (Luzern, Switzerland)
Micrometastatic node positive disease should be considered as node-negative for systemic treatment decisions

Yes (ID 72)

Lecture Time
09:10 - 09:30
Session Name
Micrometastatic node positive disease should be considered as node-negative for systemic treatment decisions
Room
Hamburg Hall
Date
Fri, 12.05.2023
Time
09:00 - 10:00
Speakers
  • Sabine C. Linn (Amsterdam, Netherlands)
Authors
  • Sabine C. Linn (Amsterdam, Netherlands)
Micrometastatic node positive disease should be considered as node-negative for systemic treatment decisions

No (ID 73)

Lecture Time
09:30 - 09:50
Session Name
Micrometastatic node positive disease should be considered as node-negative for systemic treatment decisions
Room
Hamburg Hall
Date
Fri, 12.05.2023
Time
09:00 - 10:00
Speakers
  • Joana T. Ribeiro (Villejuif, Cedex, France)
Authors
  • Joana T. Ribeiro (Villejuif, Cedex, France)
Micrometastatic node positive disease should be considered as node-negative for systemic treatment decisions

Second vote and conclusions (ID 74)

Lecture Time
09:50 - 10:00
Session Name
Micrometastatic node positive disease should be considered as node-negative for systemic treatment decisions
Room
Hamburg Hall
Date
Fri, 12.05.2023
Time
09:00 - 10:00
Speakers
  • Peter Dubsky (Luzern, Switzerland)
Authors
  • Peter Dubsky (Luzern, Switzerland)